What is Breo Ellipta?

Breo Ellipta is a combination inhaler used for managing chronic obstructive pulmonary disease (COPD) and asthma. It combines two active ingredients, fluticasone furoate (a corticosteroid) and vilanterol (a long-acting beta2-agonist or LABA), to provide long-lasting relief from symptoms and reduce inflammation. This dual-action inhaler has revolutionized treatment by offering once-daily dosing, simplifying medication regimens for patients with chronic respiratory conditions.

Uses and Benefits

Breo Ellipta is prescribed for:

• Long-term maintenance treatment of airflow obstruction in COPD patients
• Reducing COPD exacerbations in patients with a history of flare-ups
• Managing asthma in adults and children over 18 years whose condition is not adequately controlled by inhaled corticosteroids alone

With once-daily dosing, Breo Ellipta improves lung function and helps prevent worsening symptoms, ensuring better quality of life for patients. Additionally, its ease of use makes it a preferred choice for individuals who have difficulty adhering to multi-dose inhalation therapies. Patients with persistent symptoms often report enhanced symptom control and improved breathing capabilities within a few weeks of starting therapy.

How Does Breo Ellipta Work?

Breo Ellipta works by targeting two aspects of respiratory conditions:

• Fluticasone furoate: A corticosteroid that reduces inflammation in the airways, easing breathing and preventing long-term damage.
• Vilanterol: A bronchodilator that relaxes airway muscles, improving airflow for up to 24 hours and reducing the risk of acute exacerbations.

This dual-action approach ensures effective control of symptoms and helps maintain consistent breathing relief throughout the day. The combination of these agents is particularly effective in preventing nighttime symptoms, a common challenge for many patients with asthma or COPD.

Dosage and Administration

Breo Ellipta is available in two strengths: 100 mcg/25 mcg and 200 mcg/25 mcg. The appropriate dose depends on the patient’s condition:

• COPD: The 100/25 mcg strength is recommended, taken as one inhalation daily.
• Asthma: Either 100/25 mcg or 200/25 mcg may be prescribed based on disease severity. Patients with more severe asthma may benefit from the higher strength.

The inhaler should be used at the same time each day, and patients are advised to rinse their mouth with water after each use to reduce the risk of oral infections, such as thrush. Consistency in usage ensures the medication maintains its full efficacy, helping to control symptoms and prevent exacerbations effectively.

Difference Between Breo Ellipta and Trelegy Ellipta

While both Breo Ellipta and Trelegy Ellipta are inhalers designed to manage chronic respiratory conditions like COPD and asthma, there are key differences between the two that affect their use and effectiveness.

Breo Ellipta

Breo Ellipta contains two active ingredients: fluticasone (a corticosteroid) and vilanterol (a long-acting beta-agonist or LABA). It is designed to reduce inflammation and relax the airways, making it easier to breathe. Breo is commonly prescribed for moderate cases of COPD or asthma requiring dual therapy.

Trelegy Ellipta

Trelegy Ellipta contains three active ingredients: fluticasone, vilanterol, and umeclidinium (a long-acting muscarinic antagonist or LAMA). The addition of umeclidinium provides extra bronchodilation, making Trelegy a more comprehensive treatment option for severe COPD or asthma. It is often prescribed for patients who need triple therapy to manage their symptoms effectively.

Key Differences

• Active Ingredients: Breo has two (fluticasone and vilanterol), while Trelegy has three (fluticasone, vilanterol, and umeclidinium).
• Target Use: Breo is for moderate cases requiring dual therapy, while Trelegy is for more severe cases needing triple therapy.
• Scope of Relief: Trelegy provides broader symptom relief due to the additional bronchodilation from umeclidinium.

Choosing between Breo and Trelegy depends on the severity of your condition and your specific treatment needs. Consult your healthcare provider to determine which inhaler is best for you.

Why Buy Breo Ellipta from Canada?

Buying Breo Ellipta online from Canada offers significant savings compared to U.S. prices. Canadian pricing regulations make medications more affordable, allowing Americans to access the same high-quality treatments for less. Additionally, Canadian pharmacies often provide discounts and coupons for further savings. Many U.S. patients turn to Canada for cost-effective solutions without compromising on the quality or authenticity of their medication.

For patients managing chronic conditions, the opportunity to buy Breo Ellipta online from Canada provides an excellent way to reduce long-term medical expenses. This is especially true for individuals without comprehensive insurance coverage for prescription medications.

Coupons and Discounts

Take advantage of Breo Ellipta coupon codes offered by Canadian pharmacies. For example, first-time customers can use the code Hello10 for 10% off their order. These savings make buying online an even more attractive option for patients managing chronic conditions. Many pharmacies also provide discounts for bulk orders or recurring subscriptions, ensuring affordability for long-term treatment plans.

Always check with your pharmacy for the latest offers, as promotions may vary. Using coupon codes can significantly lower out-of-pocket costs, making Breo Ellipta accessible to more patients.

How Breo Ellipta Differs in the U.S. vs. Canada

The formulation of Breo Ellipta is identical in the U.S. and Canada, ensuring patients receive the same effective treatment. However, the packaging, labeling, and price may differ due to regulatory and marketing standards. Purchasing from Canada allows access to cost-effective pricing without compromising quality. Canadian pharmacies adhere to strict quality controls, ensuring the safety and effectiveness of all medications.

For Americans, the decision to buy Breo Ellipta online from Canada offers not only cost savings but also convenience. Many Canadian pharmacies offer user-friendly platforms for placing orders and delivering directly to your doorstep.

Possible Side Effects

Common side effects of Breo Ellipta include:

• Headache
• Throat irritation
• Hoarseness
• Upper respiratory tract infections
• Oral thrush

Rare but serious side effects, such as pneumonia or severe allergic reactions, require immediate medical attention. Always consult your healthcare provider if you experience unusual symptoms. Patients should also be aware of potential interactions with other medications, particularly systemic corticosteroids and certain antifungal agents.

Storage and Stability

Store Breo Ellipta at room temperature, between 15°C and 25°C (59°F to 77°F). Keep the inhaler in its original packaging to protect it from moisture and discard it 6 weeks after opening or when the dose counter reads ‘0’, whichever comes first. Proper storage ensures the medication remains effective throughout its intended use period.

Always check the expiration date on the packaging before use, and avoid exposing the inhaler to excessive heat or humidity. Proper storage practices are essential to maintaining the integrity of the medication.